Coherus BioSciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $14,307 | $12,310 | $12,748 | $11,571 |
Gross Profit | 10,065 | 7,615 | 7,807 | 6,884 |
EBITDA | -30,162 | -33,868 | -43,202 | -41,226 |
EBIT | -31,024 | -34,749 | -44,098 | -42,192 |
Net Income | -20,631 | -37,939 | -37,278 | -35,109 |
Net Change In Cash | 14,307 | 12,310 | 12,748 | 11,571 |
Free Cash Flow | -119,976 | -57,886 | -19,716 | -46,339 |
Cash | 82,923 | 115,238 | 88,879 | 103,352 |
Basic Shares | 154,816 | 136,398 | 120,369 | 116,229 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $42,172 | $266,960 | $257,244 | $211,042 |
Gross Profit | 24,434 | 149,407 | 98,252 | 140,959 |
EBITDA | -170,199 | 60,941 | -193,939 | -255,581 |
EBIT | -174,123 | 55,665 | -197,730 | -259,280 |
Net Income | -170,291 | 28,507 | -237,892 | -291,754 |
Net Change In Cash | 42,172 | 266,960 | 257,244 | 211,042 |
Cost of Revenue | -353,648 | |||
Free Cash Flow | -138,513 | -20,440 | -175,170 | -243,163 |
Cash | 88,879 | 125,987 | 102,891 | 63,547 |
Basic Shares | 120,369 | 114,830 | 94,162 | 77,630 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.22 |
2026-03-31 | -$0.25 |
2025-12-31 | -$0.34 |
2025-09-30 | -$0.33 |